Jennifer A Ligibel

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi Impact of a telephone-based physical activity intervention upon exercise behaviors and fitness in cancer survivors enrolled in a cooperative group setting
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 450 Brookline Ave Boston, Boston, MA 02215, USA
    Breast Cancer Res Treat 132:205-13. 2012
  2. ncbi Obesity and breast cancer
    Jennifer Ligibel
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA
    Oncology (Williston Park) 25:994-1000. 2011
  3. ncbi Role of adjuvant and posttreatment exercise programs in breast health
    Jennifer A Ligibel
    Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA
    J Natl Compr Canc Netw 9:251-6. 2011
  4. ncbi Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer
    Jennifer A Ligibel
    Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA
    J Womens Health (Larchmt) 19:1553-9. 2010
  5. ncbi Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors
    Jennifer A Ligibel
    Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA
    Cancer Causes Control 20:1523-8. 2009
  6. ncbi Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
    Ann Surg Oncol 16:106-12. 2009
  7. ncbi Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors
    Jennifer A Ligibel
    Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Channing Laboratory, Boston, MA, USA
    J Clin Oncol 26:907-12. 2008
  8. ncbi Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions
    Jennifer A Ligibel
    Harvard Medical School, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, Massachusetts, USA
    Breast Cancer Res 7:255-7. 2005
  9. ncbi Clinical differences among the aromatase inhibitors
    Jennifer A Ligibel
    Harvard Medical School, Women's Hospital, Boston, Massachusetts 02115, USA
    Clin Cancer Res 9:473S-9S. 2003
  10. ncbi A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases
    Rachel A Freedman
    Department of Medical Oncology, Dana Farber Cancer Institute, 44 Binney Street, Harvard Medical School, Boston, MA 02115, USA
    Clin Breast Cancer 11:376-83. 2011

Detail Information

Publications13

  1. ncbi Impact of a telephone-based physical activity intervention upon exercise behaviors and fitness in cancer survivors enrolled in a cooperative group setting
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 450 Brookline Ave Boston, Boston, MA 02215, USA
    Breast Cancer Res Treat 132:205-13. 2012
    ..Lifestyle intervention research is feasible in a cooperative group setting...
  2. ncbi Obesity and breast cancer
    Jennifer Ligibel
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA
    Oncology (Williston Park) 25:994-1000. 2011
    ....
  3. ncbi Role of adjuvant and posttreatment exercise programs in breast health
    Jennifer A Ligibel
    Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA
    J Natl Compr Canc Netw 9:251-6. 2011
    ..This article reviews the growing evidence that exercise could be an important part of breast cancer survivorship, and describes current exercise guidelines for breast cancer survivors...
  4. ncbi Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer
    Jennifer A Ligibel
    Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA
    J Womens Health (Larchmt) 19:1553-9. 2010
    ..Studies have suggested that decreases in physical activity during treatment may contribute to weight gain in breast cancer patients...
  5. ncbi Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors
    Jennifer A Ligibel
    Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA
    Cancer Causes Control 20:1523-8. 2009
    ..This study examines the impact of exercise upon levels of adiponectin, high molecular weight adiponectin (HMWA), and leptin in breast cancer survivors...
  6. ncbi Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
    Ann Surg Oncol 16:106-12. 2009
    ..Women who underwent mastectomy, as well as women who were more anxious, were more likely to decrease their level of physical activity. Women with DCIS might benefit from targeted interventions to increase physical activity...
  7. ncbi Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors
    Jennifer A Ligibel
    Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Channing Laboratory, Boston, MA, USA
    J Clin Oncol 26:907-12. 2008
    ..We sought to analyze whether exercise lowered insulin concentrations in breast cancer survivors...
  8. ncbi Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions
    Jennifer A Ligibel
    Harvard Medical School, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, Massachusetts, USA
    Breast Cancer Res 7:255-7. 2005
    ..Ongoing trials will compare these approaches and guide the use of these agents in the years to come...
  9. ncbi Clinical differences among the aromatase inhibitors
    Jennifer A Ligibel
    Harvard Medical School, Women's Hospital, Boston, Massachusetts 02115, USA
    Clin Cancer Res 9:473S-9S. 2003
    ..This article explores the efficacy and tolerability of the aromatase inhibitors in both the metastatic and the adjuvant settings...
  10. ncbi A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases
    Rachel A Freedman
    Department of Medical Oncology, Dana Farber Cancer Institute, 44 Binney Street, Harvard Medical School, Boston, MA 02115, USA
    Clin Breast Cancer 11:376-83. 2011
    ..We observed modest activity with a central nervous system objective response rate of 13.3%; however, median PFS was disappointing. Further studies should focus on other agents to treat this challenging clinical problem...
  11. ncbi Mucinous breast carcinoma: a large contemporary series
    Christina R Barkley
    Department of Surgery, Brigham and Women s Hospital, Boston, MA, USA
    Am J Surg 196:549-51. 2008
    ..Mucinous breast cancer is typically associated with a favorable prognosis. This study aimed to assess recent trends and prognostic features in the treatment of mucinous breast carcinoma...
  12. ncbi Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients
    Jennifer A Ligibel
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA, USA
    Breast Cancer Res Treat 131:589-97. 2012
    ..The side effect profile of AIs in this community-based population was similar to that seen in clinical trials. These findings provide reassurance that AIs appear to be associated with few serious side effects...
  13. ncbi Trastuzumab/chemotherapy combinations in metastatic breast cancer
    Jennifer A Ligibel
    Harvard Medical School, Boston, MA 02115, USA
    Semin Oncol 29:38-43. 2002
    ....